Infectious Diseases
Should Not Kill Anyone

Universal Infectious Diseases Test (UID)

A Revolutionary Technology to Aid the Clinician

Sepsis And Its Global Impact

Sepsis is the body's extreme response to an infection and is potentially life-threatening. This occurs when a pre-existing infection
triggers a chain reaction throughout your body, often leading to shock, disability, multi organ failure, or even death.

SEPSIS IS A LEADING CAUSE OF DEATH

Source: WHO 2020 DATA
  • Sepsis 11Mn
  • TB 1.5Mn
  • Cancer 10Mn
  • Stroke 6Mn

>2 BILLION PEOPLE WITH THE FOLLOWING PRE-EXISTING
CONDITIONS ARE AT A HIGHER RISK OF SEPSIS

18.5
million
CANCER PATIENTS
422
million
DIABETES PATIENTS
>1.5
billion
HYPERTENSION PATIENTS
140
million
IMMUNE COMPROMISED PATIENTS

The Universal Infectious Diseases Test

UID Test is an NGS based culture-free test to identify causative pathogen in a quick turn around time

1200+ PATHOGENS

1200+ PATHOGENS

Comprehensive single screening test covering bacteria and fungi

ARG PROFILING

ARG PROFILING

Identifies drug resistance based on Antibiotic Resistance Gene (ARG) profile

RESULT REPORTED IN < 12 HOURS

RESULT REPORTED IN < 12 HOURS

Hands on time < 4 hours

The Current System Needs An Upgrade To Save Lives

Tests for
ID
Turn
Around Time
Pathogen
Coverage
Antibiotic
Coverage
Additional
Information
UID Test
12 hours
>1200 pathogens
ARGs
Species and Genus identification
Culture Test
2-10 Days
Culturable bacteria and fungi
Selected Panel
Molecular Test
12-24 Hours
Up to 43 pathogens
1-5 Antibiotics
Upgradation of technology on existing set up is not possible or is very difficult

Our Partners

100+

CITIES

100+

HOSPITALS

500+

DOCTORS

In the news

COVID-19 led to a spike in Tuberculosis cases in India: Experts

24 April 2022 | The Times of India

COVID-19 led to a spike in Tuberculosis cases in India: Experts

March 24 is globally observed as World Tuberculosis Day every year to raise awareness about the disease that is curable but affects approximately 4.1

Read more

Early Detection and Accurate Diagnosis crucial to make India TB Free by 2025 - HaystackAnalytics Insights

24 March 2022 | Medgate today Magazine

Early Detection and Accurate Diagnosis crucial to make India TB Free by 2025 - HaystackAnalytics Insights

A staggering 65% of the Tuberculosis cases in India are in the 15-45 age group Mortality numbers due to Tuberculosis in India are more than other South Asian neighbours a Mumbai based health-tech startup, supported by the...

Read more

HaystackAnalytics develops first Universal Infectious Disease (ID) genomic test

7 February 2022 | The Economic Times

HaystackAnalytics develops first Universal Infectious Disease (ID) genomic test

Chennai: Healthtech startup HaystackAnalytics on Monday said it has developed India’s first Universal Infectious Disease (ID) genomic test, claiming to make it the world’s first company to bring genomics based infectious diseases diagnostic to hospitals. Read more at: https://economictimes.indiatimes.com/tech/technology/haystackanalytics-develops-first-universal-infectious-disease-id-genomic-test/articleshow/89405780.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

Read more

Public Health: Tech a formidable ally against TB

22 January 2022 | Financial Express

Public Health: Tech a formidable ally against TB

Tuberculosis (TB) is one of India’s foremost public health problems. As per World Health Organisation (WHO) estimates, India has the highest burden of TB in the world. In 2021, the country witnessed a 19% upsurge in TB cases over the previous year. Despite having an aggressive TB control programme in place, drug resistance has led to the country witnessing a sharp increase in the number of cases over the last decade. By recent estimates, 75% of drug-resistant TB (DR-TB) cases remain undiagnosed, with such patients actively transmitting the disease. Diagnosing DR-TB at an early stage is a major challenge, as it can take up to three months to detect it using existing approaches. This is where genome sequencing comes in, as it enables early and accurate diagnosis of such diseases and helps cut the costs of diagnosis and therapy.

Read more

Awards & Recognition